Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 28, 2021

SELL
$5.53 - $9.28 $1.8 Million - $3.02 Million
-325,891 Closed
0 $0
Q2 2021

Jul 29, 2021

SELL
$7.84 - $12.6 $4.88 Million - $7.84 Million
-622,037 Reduced 65.62%
325,891 $2.9 Million
Q1 2021

Apr 29, 2021

BUY
$10.54 - $19.3 $161,272 - $295,309
15,301 Added 1.64%
947,928 $12 Million
Q4 2020

Jan 29, 2021

BUY
$12.79 - $17.1 $2.89 Million - $3.86 Million
225,745 Added 31.94%
932,627 $13 Million
Q3 2020

Oct 28, 2020

SELL
$12.99 - $19.41 $544,125 - $813,046
-41,888 Reduced 5.59%
706,882 $9.2 Million
Q2 2020

Jul 28, 2020

BUY
$12.19 - $22.96 $372,075 - $700,808
30,523 Added 4.25%
748,770 $13.1 Million
Q1 2020

Apr 30, 2020

BUY
$10.08 - $27.21 $774,748 - $2.09 Million
76,860 Added 11.98%
718,247 $11.2 Million
Q4 2019

Jan 29, 2020

BUY
$13.05 - $21.88 $1,592 - $2,669
122 Added 0.02%
641,387 $12.9 Million
Q3 2019

Oct 31, 2019

BUY
$14.12 - $23.44 $1.68 Million - $2.78 Million
118,675 Added 22.71%
641,265 $9.06 Million
Q1 2019

May 01, 2019

BUY
$12.46 - $22.05 $1.87 Million - $3.3 Million
149,725 Added 40.16%
522,590 $11.5 Million
Q4 2018

Jan 31, 2019

BUY
$15.43 - $32.7 $174,791 - $370,425
11,328 Added 3.13%
372,865 $6.21 Million
Q3 2018

Oct 31, 2018

BUY
$26.95 - $52.7 $4.06 Million - $7.93 Million
150,555 Added 71.36%
361,537 $18.8 Million
Q2 2018

Jul 31, 2018

BUY
$28.08 - $31.2 $5.92 Million - $6.58 Million
210,982 New
210,982 $6.03 Million

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0

About AVROBIO, Inc.


  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Emerald Mutual Fund Advisers Trust Portfolio

Follow Emerald Mutual Fund Advisers Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.